Our current data generally reflected a correlation between the prostate cancer histology and the 68Ga-PSMA-11 PET/CT uptake; however, they also identified a subpopulation of patients with clinically significant prostate cancer that demonstrated only weak tracer uptake in the index prostatic lesion. This evidence concerns the gene FOLH1 and prostate cancer.